TMCnet News
InnovoCommerce® Announces innovoPOINT® Clinical Investigator Portal Integration with Microsoft® Office 365 and Azure Active Directory for Single Sign-OnInnovoCommerce, makers off the most advanced clinical trials investigator portal solution innovoPOINT, announces integration with Microsoft (News - Alert) Office 365 using Microsoft Azure Active Directory (Azure AD) and Microsoft Access Control Services (Azure ACS) to enable single sign-on (SSO) and multi-factor authentication (MFA (News - Alert)) for enterprise life science customers. CEO Umesh Verma has been working with life science enterprises for over two decades: "Enterprises across the spectrum of the world's largest clinical trial sponsors and clinical research organizations (CROs) have been asking for these capabilities for years now and with Microsoft Azure AD and ACS (News - Alert), it couldn't be easier, more affordable, more secure, or more convenient to deliver these capabilities." The integration with Office 365 and Azure AD allows customers with existing Office 365 investments to painlessly provision access to innovoPOINT for end users in the clinical sponsor enterprise during site qualification, study start up, study conduct and close out--without creating yet-another-identity-store, increasing not only convenience for end users, but also security and compliance. Using Azure ACS also enables SSO with many standards compliant identity stores which support federated identity, whether customers utilize Office 365 or not. Along with SSO, Azure AD also allows customers to take advantage of the multi-factor authentication capabilities to add an extra layer of security. CEO Verma commented,"Thishas been the 'Holy Grail' for a while now as far as authentication is concerned; to be able to offer the convenience of SSO to the end users while still ensuring regulatory and legal compliance when it comes to identity and authorization." He continued, "The investment Microsoft has made in obtaining FedRAMP, HIPPA, and FDA 21 CFR Part 11 compliance support means that our customers can adopt this technology without hesitation." InnovoCommerce continues to invest in the Microsoft Azure platform to help deliver cost savings to customers as well as helping organizations go-live faster while delivering the future forward capabilities that customers seek. "Azure has been a pleasure to work with. We find the documentation to be excellent and the technologies are not only mature, but also proven in the enterprise. With Azure AD and Azure ACS, we've enabled SSO to the innovoPOINT investigator portal with no new code. As a platform, we can see that Microsoft has invested heavily and will continue to do so moving forward, so we are pleased to offer this as a solution to the market," said Charles Chen, InnovoCommerce's Director of Engineering. innovoPOINT is the only commercial off the shelf secure document exchange-driven investigator portal used in production environments and supporting thousands of investigators and sites in hundreds of active clinical trials across multiple sponsors. It's designed to scale and support thousands of sites across hundreds of trials by leveraging industry leading graph database technology and a distributed compute architecture. It offers pluggable integration into electronic trial master file (eTMF) document repositories as well as the ability to compile electronic investigator site files (eISFs). About InnovoCommerce InnovoCommerce is the world's leading company dedicated to secure, FDA 21 CFR Part 11 compliant cloud-enabled clinical trial investigator portal solutions. innovoPOINT is the most advanced clinical trials investigator portal product on the market. innovoPOINT is a flexible and configurable solution that can be deployed in multi-tenant environments, in third-party data center of customer choice or on customer premise. Learn more about InnovoCommerce by visiting www.innovocommerce.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20160608005493/en/ |
